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Classification 
Existence of different histologic types of bladder 
cancer: 
- Squamous cell carcinoma: herein described, 
- Transitional cell carcinoma, 
- Adenocarcinoma: rare, 
- Poorly differenciated carcinoma/small cell carcinoma, 
exceptional. 
Clinics and pathology 
Disease 
Cancer of the urothelium. 
Etiology 
Most often secondary to bilharzial infection 
(schistosoma haematobium), may be associated with 
other types of long term irritations: chronic infections, 
calculi, treatment with cyclophosphamid. 
Epidemiology 
Geographic areas of high incidence: represents 70 to 
80% of the cases of badder cancer in the Middle East
and in Africa, in particular in Egypt, were it is the most 
common adult cancer; only 5% in Europe and in the 
USA, where the transitional cell carcinoma represents 
90-95 % of cases. 
Pathology 
Grading and staging: tumours are: 
Graded by the degree of cellular atypia (G0->G3), and
staged: pTIS carcinoma in situ (but high grade), and
pTa papillary carcinoma, both mucosally confined; pT1 
lamina propria invasive; pT2 infiltrates the superficial 
muscle, and pT3a, the deep mucle; pT3b invasion into 
perivesical fat; pT4 extends into neighbouring 
structures and organs. 
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Considered to have a poorer prognosis than the 
transitional cell carcinoma. 
Cytogenetics 
Cytogenetics Morphological 
Highly complex karyotypes, yet poorly known. 
Allelic losses are frequent; the most frequent regions 
involved in loss of heterozygocity (LOH) are 3p, 8p, 
9p, 9q, 17p; the karyotype is more complex in 
advanced grades/stages, as in transitional cell 
carcinoma. 
Chromosome 7: trisomy 7 seems to be more frequent 
than in transitional cell carcinoma, and is found more 
often in advanced stages; unknown significance as +7 
may also be found in normal tissues. 
Chromosome 9: monosomy 9 is an early event and 
might even occur at dysplastic stages; allelic losses are 
frequent, mainly in 9p (65%), more often than for 
transitional cell carcinoma; LOH are found in particular 
in the locus where CDKN2/P16 sits; homozygous 
deletion of P16 is frequent (50%) and may also be 
found in squamous metaplasias from cancerous patients 
(but not in squamous metaplasias from non cancerous 
patients); trisomy 9, on the other hand, would be 
frequent in advance diseases. 
Chromosome 17: P53 is often implicated, especially n 
high grades/stages; the profile of mutations of P53 is 
different from what is found in transitional cell 
carcinoma. 
Cytogenetics Molecular 
Comparative genomic hybridization (CGH) and multi-
FISH (M-FISH) are complementary tools to determine 
respectively unbalanced segments and structural 
rearrangements in these complex karyotypes. 
Genes involved and proteins 
Note 
Multistep process; largely unknown. 
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